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We appreciate Dr. Conti’s letter regarding our recent publication
(1). He is actually not only commenting on our study but also on
the excellent accompanying editorial by Zanzonico et al. (2), who
in fact are stating that, aside from the radiation exposure using
multislice computed tomography (MSCT), the benefit of sequen-
tial procedures for identification of significant coronary lesions
would result in an estimate of 355,000 sudden deaths that might be
avoided. However, we fully agree with Dr. Conti that, although
promising, cardiac catheterization and contrast cine angiography
still remain the reference standard for patients with coronary artery
disease (CAD).
Based on the current technology, we believe the selection of
patients who should undergo an MSCT study is indeed very
crucial. It has to be questioned whether patients who are asymp-
tomatic and at low risk are indeed candidates to have this study.
Currently, no conclusive evidence justifies the relatively high
radiation exposure associated with MSCT as a noninvasive screen-
ing tool for this population. There is not enough data comparing
the impact of a carefully taken patient’s history by cardiologists
together with an exercise test. Even if MSCT studies may then be
negative, the dilemma for the cardiologist is that, given the limited
sensitivity, specificity, and negative predictive value of MSCT, this
test does not exclude CAD.
The clinical value of MSCT coronary angiography has also to be
discussed in the context of other available noninvasive imaging
techniques. The value of both nuclear imaging and stress echocar-
diography has been nicely established in patients with CAD. It
remains to be documented where, indeed, the MSCT coronary
angiography is placed within this armamentarium.
In addition, it has to be questioned whether detection of a
nonsignificant “soft” lesion may indeed be life-saving. It is well
known that so-called soft plaques, which are prone to rupture, are
in at least 40% to 50% of nonsignificant lesions. If such a lesion can
be detected by MSCT coronary angiography, what would be the
ultimate consequence? Would it lead to percutaneous coronary
intervention as a means of prevention of plaque rupture or just
intensified medical therapy? Again, we face the same dilemma in
identifying patients at high risk for plaque rupture with noninva-
sive diagnostic imaging. Patients being at high risk to develop
CAD are currently treated with aggressive medical therapy to
avoid future vascular complications. Thus, the real question is
where MSCT coronary angiography is of real help in clinical
decision making and medical treatment.
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